LeviF., LucchiniF., NegriE.: Changed trends of cancer mortality in the elderly. Ann Oncol, 12: 1467–1477, 2001.
2.
GentiliC., SanfilippoO., SilvestriniR.: Cell proliferation and its relationship to clinical features and relapse in breast cancer. Cancer, 48: 974–979, 1981.
3.
El woodJ.M., GodolphinW.: Oestrogen receptors in breast tumours: association with age, menopausal status, and epidemiological and features in 735 patients. Br J Cancer, 42: 63544, 1980.
FriedL.P., StorerD.J., KingD.E.: Diagnosis of illness presentation in the elderly. J Am Geriatric Soc, 39: 117–123, 1991.
6.
ZilemboN., BuzzoniR., CelioL.: Formestane as treatment of advanced breast cancer in elderly patients. Tumori, 80: 433–437, 1994.
7.
Pérez-CarrionR., Alberola CandelV., CalabresiF.: Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer. Ann Oncol, 5: S19–24, 1994.
8.
VenturinoA., ComandiniD., GranettC: Formestane is feasible and effective in elderly breast cancer patients with comorbidity and disability. Breast Cencer Res Treat, 62: 217222, 2000.
9.
ReedM.J., AherneG.W., GhilchikM.W.: Concentrations of oestrone and 4-hydroxyandrostenedione in malignant and normal breast tissues. Eur J Cancer, 28A: 1712–1716, 1992.
